MENU
+Compare
ORIC
Stock ticker: NASDAQ
AS OF
Oct 17 closing price
Price
$12.78
Change
-$0.52 (-3.91%)
Capitalization
1.24B

ORIC Oric Pharmaceuticals Forecast, Technical & Fundamental Analysis

ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company... Show more

ORIC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for ORIC with price predictions
Oct 17, 2025

ORIC's RSI Indicator leaves overbought zone

The 10-day RSI Oscillator for ORIC moved out of overbought territory on October 10, 2025. This could be a sign that the stock is shifting from an upward trend to a downward trend. Traders may want to look at selling the stock or buying put options. Tickeron's A.I.dvisor looked at 34 instances where the indicator moved out of the overbought zone. In of the 34 cases the stock moved lower in the days that followed. This puts the odds of a move down at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 57 cases where ORIC's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for ORIC turned negative on October 17, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 39 similar instances when the indicator turned negative. In of the 39 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ORIC declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

ORIC broke above its upper Bollinger Band on October 06, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on September 26, 2025. You may want to consider a long position or call options on ORIC as a result. In of 80 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

Following a +2 3-day Advance, the price is estimated to grow further. Considering data from situations where ORIC advanced for three days, in of 257 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 201 cases where ORIC Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.831) is normal, around the industry mean (24.226). P/E Ratio (0.000) is within average values for comparable stocks, (54.529). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.181). Dividend Yield (0.000) settles around the average of (0.036) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (349.660).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. ORIC’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ORIC’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

View a ticker or compare two or three
ORIC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

ORIC is expected to report earnings to fall 15.04% to -39 cents per share on November 10

Oric Pharmaceuticals ORIC Stock Earnings Reports
Q3'25
Est.
$-0.40
Q2'25
Missed
by $0.03
Q1'25
Beat
by $0.09
Q4'24
Missed
by $0.01
Q3'24
Missed
by $0.01
The last earnings report on August 12 showed earnings per share of -46 cents, missing the estimate of -43 cents. With 1.12M shares outstanding, the current market capitalization sits at 1.24B.
A.I. Advisor
published General Information

General Information

a clinical stage company, which engages in the development of cancer treatments that address mechanisms of therapeutic resistance

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
240 E. Grand Avenue
Phone
+1 650 388-5600
Employees
100
Web
https://www.oricpharma.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
SOPYX33.280.20
+0.60%
ClearBridge Dividend Strategy I
LAVTX17.080.08
+0.47%
Lord Abbett Fundamental Equity R5
JGERX13.290.04
+0.30%
JHancock Global Equity R2
MSCFX30.99-0.04
-0.13%
Mairs & Power Small Cap
ONERX63.24-0.64
-1.00%
One Rock

ORIC and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, ORIC has been loosely correlated with NUVL. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if ORIC jumps, then NUVL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ORIC
1D Price
Change %
ORIC100%
-3.91%
NUVL - ORIC
46%
Loosely correlated
+2.32%
KYMR - ORIC
46%
Loosely correlated
-1.04%
ERAS - ORIC
46%
Loosely correlated
-4.35%
ELVN - ORIC
45%
Loosely correlated
-1.56%
NRIX - ORIC
44%
Loosely correlated
-1.89%
More